The Nordic Colorectal Cancer Biomodulation Group
1 clinical trials · Sponsor
◉ Watch The Nordic Colorectal Cancer Biomodulation Group
| Record | Firm | Date |
|---|---|---|
| FLOX in Combination With Cetuximab in First-line Treatment of Colorectal Cancer (NCT00145314) | The Nordic Colorectal Cancer Biomodulation Group | 2005-05-01 |
Track The Nordic Colorectal Cancer Biomodulation Group automatically
Every clearance here is in the API, with alerts when new ones post.